PHINDaccess Hackathons for COVID-19 and Host-Pathogen Interaction: Lessons Learned and Recommendations for Low- and Middle-Income Countries.


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2023
Historique:
received: 15 04 2023
revised: 29 08 2023
accepted: 01 09 2023
medline: 23 10 2023
pubmed: 19 10 2023
entrez: 19 10 2023
Statut: epublish

Résumé

Hackathons are collaborative events that bring together diverse groups to solve predefined challenges. The COVID-19 pandemic caused by SARS-CoV-2 has emphasized the need for portable and reproducible genomics analysis pipelines to study the genetic susceptibility of the human host and investigate human-SARS-CoV-2 protein interactions. To build and strengthen institutional capacities in OMICS data analysis applied to host-pathogen interaction (HPI), the PHINDaccess project organized two hackathons in 2020 and 2021. These hackathons are aimed at developing bioinformatics pipelines related to the SARS-CoV-2 viral genome, its phylodynamic transmission, and the identification of human genome host variants, with a focus on addressing global health challenges, particularly in low- and middle-income countries (LMIC). This paper outlines the preparation, proceedings, and lessons learned from these hackathons, including the challenges faced by participants and our recommendations based on our experience for organizing hackathons in LMIC and beyond.

Identifiants

pubmed: 37854792
doi: 10.1155/2023/6638714
pmc: PMC10581832
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6638714

Informations de copyright

Copyright © 2023 Kais Ghedira et al.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Nucleic Acids Res. 2016 Jan 4;44(D1):D7-19
pubmed: 26615191
Int J Nurs Stud. 2020 Aug;108:103587
pubmed: 32388221
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
Brief Bioinform. 2022 Mar 10;23(2):
pubmed: 35043153
Biomed J. 2020 Aug;43(4):328-333
pubmed: 32387617
J Med Internet Res. 2020 Mar 24;22(3):e17004
pubmed: 32207691
Nucleic Acids Res. 2012 Jan;40(Database issue):D593-8
pubmed: 22006842
J Med Internet Res. 2021 Feb 8;23(2):e25283
pubmed: 33497350
Iran J Med Sci. 2020 May;45(3):157-169
pubmed: 32546882
Bioinformatics. 2009 Aug 1;25(15):1968-9
pubmed: 19497936
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Zool Res. 2020 Nov 18;41(6):705-708
pubmed: 33045776
Yi Chuan. 2020 Feb 20;42(2):212-221
pubmed: 32102777
Genome Biol. 2014;15(12):550
pubmed: 25516281
China CDC Wkly. 2021 Dec 3;3(49):1049-1051
pubmed: 34934514
NPJ Digit Med. 2021 Feb 9;4(1):18
pubmed: 33564061
Nucleic Acids Res. 2021 Jan 8;49(D1):D1534-D1540
pubmed: 33166392
Hum Mutat. 2022 Aug;43(8):998-1011
pubmed: 35088925
Nucleic Acids Res. 2021 Jan 8;49(D1):D884-D891
pubmed: 33137190
BMJ Innov. 2021 Apr 19;7(2):284-287
pubmed: 37556255
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Database (Oxford). 2021 Apr 17;2021:
pubmed: 33864455
J Med Syst. 2016 Jul;40(7):177
pubmed: 27277278
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Nucleic Acids Res. 2011 Jan;39(Database issue):D28-31
pubmed: 20972220

Auteurs

Kais Ghedira (K)

Laboratory of Bioinformatics, Biomathematics and Biostatistics LR20IPT09, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis 1002, Tunisia.

Hamza Dallali (H)

Laboratory of Biomedical Genomics and Oncogenetics (LR20IPT05), Pasteur Institute of Tunis, University of Tunis El Manar, Tunis 1002, Tunisia.

Monia Ardhaoui (M)

Department of Human and Experimentally Anatomic Pathology, Laboratory of Molecular Epidemiology and Experimental Pathology, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
Laboratory of Molecular Epidemiology and Experimental Pathology, Tunisia.

Zied Bouslema (Z)

Laboratory for Rabies Diagnostics, Institute Pasteur of Tunis, Belvedere, Tunis 1002, Tunisia.
University of Tunis El Manar, Tunis, Tunisia.

Yosr Hamdi (Y)

Laboratory of Biomedical Genomics and Oncogenetics (LR20IPT05), Pasteur Institute of Tunis, University of Tunis El Manar, Tunis 1002, Tunisia.

Salma Feki Ben-Salah (S)

Laboratory of Virus, Vector and Hosts (LR20IPT02), Institut Pasteur de Tunis, Université Tunis El Manar, Tunis 1068, Tunisia.

Hanen Chelbi (H)

Laboratory of Medical Parasitology, Biotechnology and Biomolecules, LR16IPT06, Institut Pasteur de Tunis, Université Tunis El Manar, Tunis Belvédère 1002, Tunisia.

Chiraz Atri (C)

Laboratory of Transmission, Control and Immunobiology of Infections (LTCII), LR16IPT02, Institut Pasteur de Tunis, Université Tunis El Manar, Tunis Belvédère 1002, Tunisia.

Melek Chaouch (M)

Laboratory of Bioinformatics, Biomathematics and Biostatistics LR20IPT09, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis 1002, Tunisia.

Naira Dekhil (N)

Laboratory of Molecular Microbiology, Vaccinology, And Biotechnology Development, Institut Pasteur de Tunis, Université Tunis El Manar, Tunis, Tunisia.

Afef Rais (A)

Laboratory of Transmission, Control and Immunobiology of Infections (LTCII), LR16IPT02, Institut Pasteur de Tunis, Université Tunis El Manar, Tunis Belvédère 1002, Tunisia.

Saifeddine Azouz (S)

Genomics Platform, Institut Pasteur de Tunis, Université Tunis El Manar, Tunis 1068, Tunisia.

Manel Gharbi (M)

Laboratory of Epidemiology and Veterinary Microbiology. Group of Bacteriology and Biotechnology Institut Pasteur of Tunisia, University of Tunis El Manar (UTM), Tunis 1002, Tunisia.

Fatma Guerfali (F)

Laboratory of Transmission, Control and Immunobiology of Infections (LTCII), LR16IPT02, Institut Pasteur de Tunis, Université Tunis El Manar, Tunis Belvédère 1002, Tunisia.

Chaima Hkimi (C)

Laboratory of Bioinformatics, Biomathematics and Biostatistics LR20IPT09, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis 1002, Tunisia.

Selim Kamoun (S)

Laboratory of Bioinformatics, Biomathematics and Biostatistics LR20IPT09, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis 1002, Tunisia.

Ayoub Ksouri (A)

Laboratory of Venom, Toxins and Therapeutic Molecules, Institut Pasteur Tunis, University Tunis El Manar, Tunis, Tunisia.

Imen Moumni (I)

Laboratory of Molecular and Cellular Hematology, LR16IPT07, Pasteur Institute of Tunis, University of Tunis El Manar, Tunisia.

Houyem Ouragini (H)

Laboratory of Molecular and Cellular Hematology, LR16IPT07, Pasteur Institute of Tunis, University of Tunis El Manar, Tunisia.

Raghda Bsibes (R)

Grant Office, Institut Pasteur de Tunis, Tunis, Tunisia.

Zeineb Afifi (Z)

Grant Office, Institut Pasteur de Tunis, Tunis, Tunisia.

Khouloud Youssfi (K)

Specialized Unit "Communication, Science and Society", Institut Pasteur de Tunis, Tunis, Tunisia.

Hichem Ben Hassine (H)

Specialized Unit "Communication, Science and Society", Institut Pasteur de Tunis, Tunis, Tunisia.

Najet Hadhri (N)

Grant Office, Institut Pasteur de Tunis, Tunis, Tunisia.

Helmi Mardassi (H)

Laboratory of Molecular Microbiology, Vaccinology, And Biotechnology Development, Institut Pasteur de Tunis, Université Tunis El Manar, Tunis, Tunisia.

Houcemeddine Othman (H)

Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Department of Genetics, Farhat Hached University Hospital, Sousse, Tunisia.
Laboratory of Cytogenetics, Molecular Genetics, and Reproductive Biology (LR03SP02), Farhat Hached University Hospital, Sousse, Tunisia.

Oussema Khamessi (O)

Laboratory of Venoms and Therapeutic Molecules LR11IPT08, Institut Pasteur de Tunis, University of Tunis El Manar, 13 Place Pasteur BP74Belvédère, Tunis Belvédère, Tunisia.
High Institute of Biotechnology of Sidi Thabet, University of Manouba, Ariana BP-66, Manouba 2010, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH